Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Braskem SA ( (BAK) ) has provided an announcement.
On May 14, 2025, Braskem S.A. announced a related-party transaction with Petrobras involving a five-year contract for the purchase of up to 38,000 tons of benzene. The contract, valued at approximately R$ 168 million, allows for flexible price negotiations based on international benzene prices, with no minimum volume obligations. This agreement reflects Braskem’s strategic efforts to secure essential raw materials and strengthen its supply chain, potentially impacting its operational efficiency and market positioning.
The most recent analyst rating on (BAK) stock is a Buy with a $8.50 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.
Spark’s Take on BAK Stock
According to Spark, TipRanks’ AI Analyst, BAK is a Neutral.
Braskem SA’s overall stock score reflects substantial financial challenges, including declining profitability, high leverage, and cash flow issues. While recent operational improvements and strategic initiatives are positive, the company’s high debt levels and ongoing challenges in key segments weigh heavily on its outlook. The technical analysis offers some short-term bullish indications, but the valuation remains a concern due to negative earnings.
To see Spark’s full report on BAK stock, click here.
More about Braskem SA
Braskem S.A. operates in the petrochemical industry, focusing on the production and sale of chemicals and petrochemical products. The company is a significant player in the market, with operations that include the manufacturing of various chemical products, including benzene.
Average Trading Volume: 824,708
Technical Sentiment Signal: Sell
Current Market Cap: $1.53B
Find detailed analytics on BAK stock on TipRanks’ Stock Analysis page.